The Latest Cardiac and Vascular News
Westport, CT, Dec. 03, 2019 (GLOBE NEWSWIRE) — ·The Company partners with Reified Capital, a provider of advanced artificial intelligence-focused technical advisory services to the private sector ·Collaboration to focus on machine learning and artificial intelligence solutions for healthcare ·Initial solutions to be centered on BioSig’s core competencies in electrophysiology BioSig Technologies, Inc. (NASDAQ: BSGM) […]
Westport, CT, Nov. 26, 2019 (GLOBE NEWSWIRE) — ·New areas of collaboration identified between Mayo Clinic and BioSig ·Focus on previously untapped arrhythmia treatments ·Additional development areas covering novel therapies for autonomic nervous system disease BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform […]
Westport, CT, Nov. 21, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the Company commenced its first clinical trial for its […]
BioSig Supports the Alliance for Advancing Bioelectronic Medicine, Which Seeks to Bring Together Leading Experts to Advance Entire Field Westport, CT, Nov. 18, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “The Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the […]
Highlights include PURE EP™ System commercialization plans for 2020, clinical trial and installation updates on PURE EP™ System and other business development advancements Westport, CT, Nov. 14, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal […]
Former Investment Officer at Mayo Clinic to oversee relationships in the Midwest Westport, CT, Nov. 06, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “The Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, […]
Westport, CT, Oct. 29, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “The Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the Company appointed Mr. Andrew (“Andy”) Gornell Ballou as […]
Westport, CT, Oct. 15, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “The Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the Company is opening a new technology development office […]
Westport, CT, Sept. 05, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that its subsidiary, NeuroClear Technologies, Inc., raised $3.7 million in an initial seed round. Founded in November 2018, NeuroClear […]
Westport, CT, Aug. 01, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that the US Patent Office has allowed another foundational patent including additional 29 patent claims covering its PURE EPTM System. The […]
